Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

2007 • 3,950 citations

Guidelines for Treatment of Candidiasis

2004 • 1,463 citations

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1991 • 957 citations

Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

2008 • 951 citations

Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

1995 • 820 citations

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1996 • 779 citations

The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species

1997 • 774 citations

Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus

2004 • 691 citations

Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients

1995 • 562 citations

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

2005 • 522 citations

Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole

2000 • 506 citations

Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

2003 • 503 citations

Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy

1985 • 493 citations

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

2004 • 422 citations

Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline

2009 • 404 citations

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

2008 • 366 citations

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

2006 • 289 citations

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

2007 • 284 citations

Current Treatment Strategies for Disseminated Candidiasis

2005 • 261 citations

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

2006 • 257 citations

The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal Infections

1980 • 220 citations

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

2006 • 195 citations

Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen

1994 • 182 citations

Candida guilliermondii , an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

2006 • 175 citations

Candida krusei Fungemia

2000 • 168 citations

Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage

2006 • 164 citations

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole

2005 • 163 citations

In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood

2003 • 162 citations

Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study

2005 • 153 citations

Emergence of a Candida krusei Isolate with Reduced Susceptibility to Caspofungin during Therapy

2006 • 146 citations

Increased incidence of fungemia caused by Candida krusei

1986 • 145 citations

Voriconazole Salvage Treatment of Invasive Candidiasis

2003 • 127 citations

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

2002 • 125 citations

Increase in prevalence of nosocomial non- Candida albicans candidaemia and the association of Candida krusei with fluconazole use

2002 • 123 citations

Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase

2007 • 113 citations

Patterns of Amphotericin B Killing Kinetics against Seven Candida Species

2004 • 113 citations

Candida rugosa , an Emerging Fungal Pathogen with Resistance to Azoles: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

2006 • 93 citations

Vaginitis Due toCandida krusei:Epidemiology, Clinical Aspects, and Therapy

2002 • 93 citations

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

2001 • 93 citations

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

2003 • 92 citations

Global Surveillance of In Vitro Activity of Micafungin against Candida : a Comparison with Caspofungin by CLSI-Recommended Methods

2006 • 88 citations

Predictive value of surveillance cultures for systemic infection due toCandida species

1987 • 81 citations

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital

2005 • 80 citations

Candida krusei Fungemia

1993 • 77 citations

Invasive Infection Due to Candida krusei in Immunocompromised Patients Not Treated with Fluconazole

1995 • 76 citations

Candida Prosthetic Valve Endocarditis Cured by Caspofungin Therapy without Valve Replacement

2005 • 61 citations

Emergence of disseminated candidiasis caused byCandida kruseiduring treatment with caspofungin: Case report and review of literature

2005 • 56 citations

Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species

2004 • 53 citations

In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei

2004 • 47 citations

Strain variation among and antifungal susceptibilities of isolates of Candida krusei

1996 • 45 citations

Candida kruseisepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient

2007 • 31 citations

Candida krusei Transmission among Hematology Patients Resolved by Adapted Antifungal Prophylaxis and Infection Control Measures

2006 • 29 citations

Spondylodiscitis Caused by Candida krusei : Case Report and Susceptibility Patterns

2006 • 28 citations

Molecular typing for investigating an outbreak of Candida krusei

1996 • 18 citations

Eight-Year Surveillance of Non-Albicans Candida spp. in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis

1997 • 15 citations

Successful treatment of Candida krusei infection with caspofungin acetate: A new antifungal agent

2003 • 15 citations

SepticCandida kruseithrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents

2005 • 12 citations

Successful treatment ofCandida kruseifungemia with amphotericin B and caspofungin

2006 • 11 citations

Candida kruseirenal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome®

2003 • 10 citations

Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study

2006 • 8 citations